IRIS
DE FABRITIIS, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.267
AS - Asia 4.968
EU - Europa 3.538
SA - Sud America 807
AF - Africa 70
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 44.668
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.125
SG - Singapore 2.530
CN - Cina 804
RU - Federazione Russa 694
BR - Brasile 660
HK - Hong Kong 615
DE - Germania 596
IT - Italia 566
UA - Ucraina 436
VN - Vietnam 434
IE - Irlanda 379
GB - Regno Unito 233
FR - Francia 187
JP - Giappone 176
FI - Finlandia 120
KR - Corea 95
SE - Svezia 93
CA - Canada 68
IN - India 64
MX - Messico 51
AR - Argentina 49
PL - Polonia 47
NL - Olanda 41
AT - Austria 37
BD - Bangladesh 36
TR - Turchia 30
IQ - Iraq 28
ZA - Sudafrica 24
ID - Indonesia 22
EC - Ecuador 20
ES - Italia 19
BE - Belgio 18
UZ - Uzbekistan 18
PY - Paraguay 16
CL - Cile 15
PK - Pakistan 15
CO - Colombia 14
PH - Filippine 12
RO - Romania 12
CZ - Repubblica Ceca 11
VE - Venezuela 11
KE - Kenya 10
AU - Australia 9
GR - Grecia 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
IL - Israele 8
IR - Iran 8
LT - Lituania 8
MA - Marocco 8
JO - Giordania 7
KZ - Kazakistan 7
CH - Svizzera 6
EU - Europa 6
PT - Portogallo 6
SA - Arabia Saudita 6
BO - Bolivia 5
HR - Croazia 5
NP - Nepal 5
QA - Qatar 5
TH - Thailandia 5
AZ - Azerbaigian 4
DM - Dominica 4
KG - Kirghizistan 4
SN - Senegal 4
TW - Taiwan 4
AL - Albania 3
CR - Costa Rica 3
GY - Guiana 3
HU - Ungheria 3
JM - Giamaica 3
MY - Malesia 3
NG - Nigeria 3
PA - Panama 3
SV - El Salvador 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AM - Armenia 2
DK - Danimarca 2
ET - Etiopia 2
LB - Libano 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
Totale 44.653
Salva come PNG Salva come JPEG
Città #
Woodbridge 9.465
Wilmington 8.703
Houston 7.492
Singapore 1.387
Fairfield 1.120
Ann Arbor 869
Ashburn 823
San Jose 652
Chandler 616
Hong Kong 603
Seattle 470
Cambridge 393
Jacksonville 376
Dublin 361
Beijing 334
Medford 267
Santa Clara 245
New York 224
The Dalles 213
Dearborn 210
Rome 181
Dallas 158
Los Angeles 156
Ho Chi Minh City 154
Tokyo 149
Lawrence 127
Moscow 124
Buffalo 100
Hanoi 98
Colorado Springs 94
Lauterbourg 91
Zhengzhou 78
Council Bluffs 70
Mülheim 64
San Diego 64
São Paulo 63
Milan 52
Menlo Park 45
Munich 45
London 35
Corona 34
Montreal 31
Chicago 26
Helsinki 26
Nuremberg 26
Brooklyn 25
Norwalk 24
Redondo Beach 24
Frankfurt am Main 23
University Park 23
Denver 22
Phoenix 22
Warsaw 22
Boardman 21
Bologna 21
Orem 21
Atlanta 20
Falls Church 19
Johannesburg 19
Mexico City 19
Brussels 18
Shanghai 18
Toronto 18
Chennai 17
Nanjing 17
Naples 17
Amsterdam 16
Belo Horizonte 16
Hefei 16
Kraków 16
Mountain View 16
North Bergen 16
Rio de Janeiro 16
Vienna 16
Da Nang 15
Haiphong 15
Verona 15
Poplar 14
Stockholm 14
Redwood City 13
Washington 13
Brasília 12
Kunming 12
San Francisco 12
Baghdad 11
Boston 11
Manchester 11
Mumbai 11
Seoul 11
Dhaka 10
Jakarta 10
Palo Alto 10
Chiswick 9
Creede 9
Curitiba 9
Guangzhou 9
Hải Dương 9
Miami 9
Querétaro 9
Salt Lake City 9
Totale 37.764
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 627
Cistite emorragica da Adenovirus in un paziente sottoposto a trapianto di midollo osseo. vol. 39, p. 977-978 499
Acute foetal distress and umbilical cord blood banking 496
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 493
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 486
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: Retrospective analysis of 530 patients 473
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report 472
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 471
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. 469
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry 465
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease. 459
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components 458
IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: an exceptionally rare observation. 457
Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera 457
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: Results of a randomized phase III trial of the EORTC and GIMEMA consortium (AML-17) 457
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 453
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 449
Characterization of Ph-negative abnormal clones emerging during imatinib therapy 443
Koebner's phenomenon as a rare mechanism of acute myeloid leukemia dissemination: report of two cases with a brief overview 442
Unrelated Cord Blood transplantaion for children with high risk myelodysplastic syndrome 440
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825 438
Pure erythroid leukemia in advanced breast cancer. 438
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 437
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia 437
Management of hematological malignancies in patients affected by renal failure 436
Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab 436
Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes 436
Cutaneous involvement in multiple myeloma and bortezomib 435
Evaluation of biological features of cord blood units collected with different methods after cesarean section 427
The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes 427
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA) 426
Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy 425
Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. 424
Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase 424
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 423
Cold autoimmune hemolytic anemia resolved by rituximab 422
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 421
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 419
Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting. 417
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 416
Bortezomib-related colon mucositis in a multiple myeloma patient 416
Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab. 412
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors 411
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 411
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 411
null 410
Immunophenotypic analysis in 119 patients with acute myeloid leukemia following a previous malignancy: a comparison with the immunophenotype of 231 de novo cases 409
Home care management of patients affected by hematologic malignancies: A review 408
Bortezomib: Efficacy comparisons in solid tumors and hematologic malignancies 408
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia 403
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 403
Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units 401
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow 399
Triple immunofluorescence evaluation of CD15, CD34 and Class-II expression by flow-cytometry in normal and leukemic bone marrows 398
Molecular evidence of transient complete remission after autografting in Ph-/bcr rearranged chronic myelogenous leukaemia 395
The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia 394
Complete remission through blast cell differentiation in PLZF/RARα-positive acute promyelocytic leukemia: In vitro and in vivo studies 394
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis 392
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion 391
Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures 388
Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting 386
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial 386
null 385
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE 382
Opioids in pain management of blood-related malignancies 381
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts 380
Sleep complaints in hospitalized Italian patients with hematological malignancies 378
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy 375
Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease 374
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 373
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia 368
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 365
Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy? 365
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 365
Primary pulmonary hodgkin lymphoma simulating a mediastinal tumour: an uncommon occurrence. 364
Stem cell mobilization after coronary artery bypass grafting. 362
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 358
CD69 is independently prognostic in chronic lymphocytic leukemia: acomprehensive clinical and biological profiling study 355
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 351
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 351
Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient 332
Pain management in multiple myeloma. 332
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825. 327
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 308
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 294
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 294
Gender, age and diagnosis effect on self-perceived pain in hematological patients: Retrospective analysis of two case series 294
Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Frontline Azacytidine Treatment 219
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 202
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions 202
Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party 201
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy 197
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 188
Bone marrow aspiration and biopsy-related pain management 180
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation 179
Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score 179
Chemotherapy induced nausea and vomiting in bone marrow transplant: the unmet need 177
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network 170
Management of pregnant chronic myeloid leukemia patients 167
Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network 165
Totale 38.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.827
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021496 0 0 0 0 0 0 0 0 0 196 229 71
2021/20221.272 61 169 53 52 45 113 75 76 70 102 79 377
2022/20231.951 183 144 60 184 124 368 153 91 142 344 117 41
2023/2024916 97 30 79 41 115 217 31 49 25 24 42 166
2024/20253.775 115 895 417 219 137 180 353 142 377 389 280 271
2025/20265.983 547 421 835 529 625 229 823 663 783 528 0 0
Totale 45.176